A multicenter, open-label, phase 2 study of NGX-4010 [capsaicin] for the treatment of neuropathic pain in patients with painful HIV-associated neuropathy (HIV-AN) or postherpetic neuralgia (PHN)

Trial Profile

A multicenter, open-label, phase 2 study of NGX-4010 [capsaicin] for the treatment of neuropathic pain in patients with painful HIV-associated neuropathy (HIV-AN) or postherpetic neuralgia (PHN)

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2008

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Mar 2008 Status changed from in progress to completed.
    • 06 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top